Author response: Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
Mona Seifert(Friedrich-Alexander-Universität Erlangen-Nürnberg), David Dulin(Vrije Universiteit Amsterdam), Thi-Tuyet-Nhung Le(Centre National de la Recherche Scientifique), Xiangzhi Meng(University of California, Los Angeles), Pauline van Nies(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jamie J. Arnold(University of North Carolina at Chapel Hill), Ashleigh Shannon(Architecture et Fonction des Macromolécules Biologiques), Bruno Canard(Architecture et Fonction des Macromolécules Biologiques), Tyler L. Grove(Albert Einstein College of Medicine), Flávia S. Papini(Friedrich-Alexander-Universität Erlangen-Nürnberg), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), James M. Wood(Victoria University of Wellington), Lawrence D. Harris(Victoria University of Wellington), Yan Xiang(Sichuan University), Robert N. Kirchdoerfer(Scripps Research Institute), Hongjie Xia(The University of Texas Medical Branch at Galveston), Subhas Chandra Bera(Friedrich-Alexander-Universität Erlangen-Nürnberg), Steven C. Almo(Albert Einstein College of Medicine), Craig Cameron(University of North Carolina at Chapel Hill), Martin Depken(Max Planck Institute for the Physics of Complex Systems)
Cited by 1
Related Papers
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k